Cardium Therapeutics - Dividend History | CRXM

Historical dividend payout and yield for Cardium Therapeutics (CRXM) since 1971. The current TTM dividend payout for Cardium Therapeutics (CRXM) as of December 31, 1969 is $0.00. The current dividend yield for Cardium Therapeutics as of December 31, 1969 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.000B
Taxus Cardium Pharmaceuticals Group Inc. operates as a development stage advanced regenerative therapeutics company. It is focused on the late-stage clinical and commercial development of regenerative medicine therapeutics. The company provides Generx (R) for the treatment of cardiac microvascular insufficiency due to advancing coronary artery disease, and Excellagen (R), for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. Taxus Cardium Pharmaceuticals Group Inc., formerly known as Cardium Therapeutics, Inc., is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio